Zinc has an important place amongst inhibitors of crystallisation and
crystal growth. These views are supported by in vivo and in vitro stud
ies which suggest that the urinary zinc level is a significant factor
in urolithiasis. Some recent studies have given contradictory results.
Blood serum and urinary zinc levels were measured in 30 normal health
y controls and 42 stone forming patients (renal, ureteric and vesical)
. Statistically significant levels were found in all groups, varying a
ccording to the number of calculi. Increased urinary zinc levels and d
ecreased serum zinc levels appear to be secondary to the process of st
one formation. The role of zinc as an inhibitor of urolithiasis is que
stionable.